iHealthtech’s Dr Gloryn Chia named EMBO Global Investigator
- December 24, 2025
Photo credit: NUS iHealthtech
iHealthtech Principal Investigator Dr Gloryn Chia has been selected as an EMBO Global Investigator in recognition of her impactful research on cancer immunotherapies.
As an EMBO Global Investigator, Dr Chia will join an international network of more than 800 current and former EMBO Young Investigators, Global Investigators, and Installation Grantees, and will be eligible to participate in EMBO events. The programme provides opportunities to build collaborations with scientists in the asia-pacific region and across Europe.
Congratulations to Dr Chia!
Related News:
🌐 NUSnews: NUS researchers selected for prestigious EMBO Global Investigator Network 2025
